Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

New antimalarial agent submitted to extensive clinical testing

Jan. 19, 1998

U. of Mass. scientists design anti-EBV antisense oligonucleotides

Jan. 16, 1998

Lilly describes new glycopeptides active against VRE

Jan. 15, 1998

Genzyme Transgenics breakthrough could lead to potential malaria vaccine

Jan. 14, 1998

Carbapenems with enhanced antipseudomonal activity and stability

Jan. 14, 1998

DuPont Merck, Signal collaborate on HCV and HIV research

Jan. 14, 1998

Preclinical and preliminary clinical results reported for CS-834

Jan. 14, 1998

Two SBIR grants awarded to Cubist for antiinfective drug discovery

Jan. 12, 1998

New antiviral peptides from Boehringer Ingelheim

Jan. 12, 1998

Dainippon in-licenses Wakunaga fluoroquinolone

Jan. 12, 1998

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...